BERLIN, Aug. 22, 2008 (GLOBE NEWSWIRE) --

 Issuer:

 Epigenomics AG 
 - ISIN DE000A0BVT96 - 
 Kleine Prasidentenstr. 1
 10178 Berlin 
 Deutschland

Voting Rights Notification:

On 21 August 2008 Federated Investors Inc., Pittsburgh, USA made the following notifications regarding the holding of voting rights held in Epigenomics AG, Berlin, Germany, according to article 21 WpHG in their name as well as for their subsidiary F II Holdings Inc., Pittsburgh, USA:

1.) Notification of voting rights in the name and on behalf of F II Holdings Inc. pursuant to article 21 para. 1 WpHG:

On 1 April 2008 F II Holdings Inc. fell below the 3 per cent, the 5 per cent, the 10 per cent and the 15 per cent thresholds of article 21 para. 1 WpHG and held at this date 0 per cent of the voting rights (0 voting rights) in Epigenomics AG.

2.) Notification of voting rights in their own name pursuant to article 21 para. 1 WpHG:

On 1 April 2008 Federated Investors Inc. fell below the 3 per cent, the 5 per cent, the 10 per cent and the 15 per cent thresholds of article 21 para. 1 WpHG and held at this date 0 per cent of the voting rights (0 voting rights) in Epigenomics AG.

Voluntary Clarification:

Further on the same day, Federated Investors Inc. made the following voluntary clarification in addition to their notifications pursuant to articles 21 et seq. WpHG reported above regarding the holding of voting rights held in Epigenomics AG for Federated Kaufmann Fund Federated Investors Fund, Pittsburgh, USA as well as for Federated Equity Management Company of Pennsylvania, Pittsburgh, USA:

1.) Clarification of voting rights in the name and on behalf of the Federated Kaufmann Fund:

As of 1 April 2008 Federated Kaufmann Fund still held 19.02 per cent of the voting rights (5.081.706 voting rights) in Epigenomics AG.

2.) Clarification of voting rights in the name and on behalf of the of Federated Equity Management Company of Pennsylvania:

As of 1 April 2008 Federated Equity Management Company of Pennsylvania still held 19.26 per cent of the voting rights (5.143.405 voting rights) in Epigenomics AG. 19.26 per cent of the voting rights (5.143.405 voting rights) are attributed to Federated Equity Management Company of Pennsylvania pursuant to article 22 para. 1 sent. 1 no. 6 WpHG. Voting rights are attributed to Federated Equity Management Company of Pennsylvania by Federated Kaufmann Fund which held directly 3 per cent or more of voting rights.

Federated Investors Inc. are the parent company of F II Holdings Inc., which in turn is the parent company of Federated Equity Management Company of Pennsylvania. Federated Equity Management Company of Pennsylvania, an investment adviser registered in the United States under the Investment Company Act of 1940, acts as Investment Adviser to the Federated Kaufmann Fund and Federated Kaufmann Fund II, both Massachusetts Business Trusts and Investment Companies, as that term is defined under the Investment Company Act 1940.

Date of release: 22 August 2008

 Epigenomics AG 
 The Executive Board

          Epigenomics AG 
          Dr. Achim Plum, Sr. Vice President 
           Corporate Development 
          +49 (0)30 24345 368 
          Fax: +49 (0)30 24345 555 
          achim.plum@epigenomics.com